Society for Immunotherapy of Cancer (SITC) shared a post on LinkedIn:
“Immune cell engagers are transforming cancer treatment.
Join Anna Farago, MD, PhD, to learn how these therapies are advancing and what they could mean for patients and drug developers.
Sept. 3–4 in Lausanne, Switzerland.”
2026 SITC EU Immuno-Oncology Drug Development Summit
Other articles featuring SITC on OncoDaily.